Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities

[Image: see text] The inhibition of p53-MDM2 interaction is a promising new approach to non-genotoxic cancer treatment. A potential application for drugs blocking the p53-MDM2 interaction is acute myeloid leukemia (AML) due to the occurrence of wild type p53 (wt p53) in the majority of patients. Alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yijun, Wolf, Siglinde, Beck, Barbara, Köhler, Lisa-Maria, Khoury, Kareem, Popowicz, Grzegorz M., Goda, Sayed K, Subklewe, Marion, Twarda, Aleksandra, Holak, Tad A., Dömling, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985958/
https://www.ncbi.nlm.nih.gov/pubmed/24405416
http://dx.doi.org/10.1021/cb400728e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985958/
https://www.ncbi.nlm.nih.gov/pubmed/24405416
http://dx.doi.org/10.1021/cb400728e

Ejemplares similares